Solid formulation

US11135170B2 · kind B2 · utility

Assignee

• ENESI PHARMA LIMITED · GB

Inventors

• Wei Tian · Gately Drive, SE
• Richard Zajicek · Abingdon, GB

Key dates

• Filing date: Oct 20, 2016
• Grant date: Oct 5, 2021
• Expiry date: Oct 20, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A solid dosage form for injection and a method of making said dosage form wherein the dosage form has a moisture content of 5% (w/w) or less. The solid dosage form comprises a dried matrix including a first excipient and 0.01 to 50% (w/w) or more than 50% and up to 80% (w/w) of a therapeutic peptide; and one or more additional excipients and at least 5% (w/w) of CMC, based on the total weight of the solid dosage form, wherein the dosage form has a width of 0.5 mm to 2 mm.